1. Home
  2. PTY vs TXG Comparison

PTY vs TXG Comparison

Compare PTY & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco Corporate & Income Opportunity Fund

PTY

Pimco Corporate & Income Opportunity Fund

HOLD

Current Price

$12.25

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$21.37

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTY
TXG
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
PTY
TXG
Price
$12.25
$21.37
Analyst Decision
Hold
Analyst Count
0
15
Target Price
N/A
$20.25
AVG Volume (30 Days)
1.1M
2.3M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
76.97
EPS
N/A
N/A
Revenue
N/A
$245,893,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
68.06
52 Week Low
$11.58
$7.72
52 Week High
$14.69
$26.45

Technical Indicators

Market Signals
Indicator
PTY
TXG
Relative Strength Index (RSI) 54.17 45.49
Support Level $11.97 $11.62
Resistance Level $12.36 $23.43
Average True Range (ATR) 0.10 1.34
MACD 0.03 -0.40
Stochastic Oscillator 71.79 13.82

Price Performance

Historical Comparison
PTY
TXG

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: